Judging from some of the NMS II comment letters, many in the industry would like data to be complimentary, as in completely free of charge. But one comment in the file proposes (Note 14) that exchange ...
The market for complement inhibitors is expected to grow significantly in the coming years. Since the launch of SOLIRIS and ULTOMIRIS, the complement inhibitor market has seen a lot of traction, and ...
Complement is a key component of immunity with crucial inflammatory and opsonic properties; inappropriate activation of complement triggers or exacerbates inflammatory disease. Complement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback